Isoflurane regulates atypical type-a γ-aminobutyric acid receptors in alveolar type II epithelial cells

Anesthesiology

Volumn 118, Issue 5, 2013, Pages 1065-1075

  Xiang, Yun Yan ^a   Chen, Xuanmao ^a,b   Li, Jingxin ^c   Wang, Shuanglian ^a   Faclier, Gil ^c   MacDonald, John F ^a   Hogg, James C ^d,e   Orser, Beverley A ^c   Lu, Wei Yang ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; BICUCULLINE; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL; CYCLOOXYGENASE 2; GLUTAMATE DECARBOXYLASE; ISOFLURANE; MUSCIMOL; PROSTAGLANDIN E2; SEVOFLURANE;

ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CELL MEMBRANE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DESENSITIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ALVEOLUS CELL TYPE 2; MEMBRANE DEPOLARIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN QUATERNARY STRUCTURE; STEADY STATE; UPREGULATION; VOLTAGE CLAMP;

ANESTHETICS, INHALATION; ANIMALS; BICUCULLINE; BLOTTING, WESTERN; COLORING AGENTS; CYCLOOXYGENASE 2; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GABA AGONISTS; GABA ANTAGONISTS; HUMANS; ISOFLURANE; MICE; MICROSCOPY, CONFOCAL; MUSCIMOL; PATCH-CLAMP TECHNIQUES; PULMONARY ALVEOLI; RECEPTORS, GABA-A; SOLUTIONS; TRYPAN BLUE;

EID: 84877579220     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31828e180e     Document Type: Article

References (51)

1. Gladkevich A, Korf J, Hakobyan VP, Melkonyan KV: The peripheral GABAergic system as a target in endocrine disorders. Auton Neurosci 2006; 124:1-8
2. Jin N, Narasaraju T, Kolliputi N, Chen J, Liu L: Differential expression of GABAA receptor pi subunit in cultured rat alveolar epithelial cells. Cell Tissue Res 2005; 321:173-83
3. Jin N, Kolliputi N, Gou D, Weng T, Liu L: A novel function of ionotropic gamma-aminobutyric acid receptors involving alveolar fluid homeostasis. J Biol Chem 2006; 281:36012-20
4. Xiang YY, Wang S, Liu M, Hirota JA, Li J, Ju W, Fan Y, Kelly MM, Ye B, Orser B, O'Byrne PM, Inman MD, Yang X, Lu WY: A GABAergic system in airway epithelium is essential for mucus overproduction in asthma. Nat Med 2007; 13:862-7
5. Longoni B, Demontis GC, Olsen RW: Enhancement of gamma-aminobutyric acidA receptor function and binding by the volatile anesthetic halothane. J Pharmacol Exp Ther 1993; 266:153-9
6. Wu J, Harata N, Akaike N: Potentiation by sevoflurane of the gamma-aminobutyric acid-induced chloride current in acutely dissociated CA1 pyramidal neurones from rat hippocampus. Br J Pharmacol 1996; 119:1013-21
7. Hemmings HC Jr, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL: Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci 2005; 26:503-10
8. Froh D, Gonzales LW, Ballard PL: Secretion of surfactant protein A and phosphatidylcholine from type II cells of human fetal lung. Am J Respir Cell Mol Biol 1993; 8:556-61
9. Li H, Bradbury JA, Dackor RT, Edin ML, Graves JP, DeGraff LM, Wang PM, Bortner CD, Maruoka S, Lih FB, Cook DN, Tomer KB, Jetten AM, Zeldin DC: Cyclooxygenase-2 regulates Th17 cell differentiation during allergic lung inflammation. Am J Respir Crit Care Med 2011; 184:37-49
10. Giraud O, Molliex S, Rolland C, Lecon-Malas V, Desmonts JM, Aubier M, Dehoux M: Halogenated anesthetics reduce interleukin-1beta-induced cytokine secretion by rat alveolar type II cells in primary culture. Anesthesiology 2003; 98:74-81
11. Fortis S, Spieth PM, Lu WY, Parotto M, Haitsma JJ, Slutsky AS, Zhong N, Mazer CD, Zhang H: Effects of anesthetic regimes on inflammatory responses in a rat model of acute lung injury. Intensive Care Med 2012; 38:1548-55
12. Li YW, Yang TD, Liu QY, Tao J, Huang H: Isoflurane reduces the synthesis of surfactant-related protein a of alveolar type II cells injured by H2O2. Drug Metabol Drug Interact 2007; 22:187-94
13. Voigtsberger S, Lachmann RA, Leutert AC, Schlapfer M, Booy C, Reyes L, Urner M, Schild J, Schimmer RC, Beck-Schimmer B: Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide-induced lung injury. Anesthesiology 2009; 111:1238-48
14. Reutershan J, Chang D, Hayes JK, Ley K: Protective effects of isoflurane pretreatment in endotoxin-induced lung injury. ANESTHESIOLOGY 2006; 104:511-7
15. Ding L, Quinlan KB, Elliott WM, Hamodat M, Paré PD, Hogg JC, Hayashi S: A lung tissue bank for gene expression studies in chronic obstructive pulmonary disease. COPD 2004; 1:191-204
16. Gosselink JV, Hayashi S, Chau E, Cooper J, Elliott WM, Hogg JC: Evaluation of small sample cDNA amplification for microdissected airway expression profiling in COPD. COPD 2007; 4:91-105
17. Hoshino Y, Mio T, Nagai S, Miki H, Ito I, Izumi T: Cytotoxic effects of cigarette smoke extract on an alveolar type II cellderived cell line. Am J Physiol Lung Cell Mol Physiol 2001; 281:L509-16
18. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR: Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996; 153(6 pt 1):1850-6
19. Rudolph U, Knoflach F: Beyond classical benzodiazepines: Novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 2011; 10:685-97
20. Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther 2002; 300:2-8
21. Connolly CN, Krishek BJ, McDonald BJ, Smart TG, Moss SJ: Assembly and cell surface expression of heteromeric and homomeric gamma-aminobutyric acid type A receptors. J Biol Chem 1996; 271:89-96
22. Dong H, Xiang YY, Farchi N, Ju W, Wu Y, Chen L, Wang Y, Hochner B, Yang B, Soreq H, Lu WY: Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons. J Neurosci 2004; 24:8950-60
23. Xiang YY, Dong H, Wan Y, Li J, Yee A, Yang BB, Lu WY: Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor. J Biol Chem 2006; 281:19358-68
24. Bae JJ, Xiang YY, Martinez-Canabal A, Frankland PW, Yang BB, Lu WY: Increased transforming growth factor-β1 modulates glutamate receptor expression in the hippocampus. Int J Physiol Pathophysiol Pharmacol 2011; 3:9-20
25. Caraiscos VB, Newell JG, You-Ten KE, Elliott EM, Rosahl TW, Wafford KA, MacDonald JF, Orser BA: Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane. J Neurosci 2004; 24:8454-8
26. Lu WY, Xiong ZG, Orser BA, MacDonald JF: Multiple sites of action of neomycin, Mg2+ and spermine on the NMDA receptors of rat hippocampal CA1 pyramidal neurones. J Physiol (Lond) 1998; 512 (pt 1):29-46
27. Lu W, Man H, Ju W, Trimble WS, MacDonald JF, Wang YT: Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 2001; 29:243-54
28. Cagnina RE, Ramos SI, Marshall MA, Wang G, Frazier CR, Linden J: Adenosine A2B receptors are highly expressed on murine type II alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2009; 297:L467-74
29. Orser BA, Wang LY, Pennefather PS, MacDonald JF: Propofol modulates activation and desensitization of GABAA receptors in cultured murine hippocampal neurons. J Neurosci 1994; 14:7747-60
30. Lemkuil BP, Head BP, Pearn ML, Patel HH, Drummond JC, Patel PM: Isoflurane neurotoxicity is mediated by p75NTRRhoA activation and actin depolymerization. Anesthesiology 2011; 114:49-57
31. Hedblom E, Kirkness EF: A novel class of GABAA receptor subunit in tissues of the reproductive system. J Biol Chem 1997; 272:15346-50
32. Neelands TR, Macdonald RL: Incorporation of the pi subunit into functional gamma-aminobutyric Acid(A) receptors. Mol Pharmacol 1999; 56:598-610
33. Johnston GA: GABAc receptors: Relatively simple transmittergated ion channels Trends Pharmacol Sci 1996; 17:319-23
34. Enz R, Cutting GR: GABAC receptor rho subunits are heterogeneously expressed in the human CNS and form homoand heterooligomers with distinct physical properties. Eur J Neurosci 1999; 11:41-50
35. Milligan CJ, Buckley NJ, Garret M, Deuchars J, Deuchars SA: Evidence for inhibition mediated by coassembly of GABAA and GABAC receptor subunits in native central neurons. J Neurosci 2004; 24:7241-50
36. Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev 1999; 29:196-217
37. Steiger JL, Russek SJ: GABAA receptors: Building the bridge between subunit mRNAs, their promoters, and cognate transcription factors. Pharmacol Ther 2004; 101:259-81
38. Barnes EM Jr: Use-dependent regulation of GABAA receptors. Int Rev Neurobiol 1996; 39:53-76
39. Benkwitz C, Banks MI, Pearce RA: Influence of GABAA receptor gamma2 splice variants on receptor kinetics and isoflurane modulation. Anesthesiology 2004; 101:924-36
40. Kolodsick JE, Peters-Golden M, Larios J, Toews GB, Thannickal VJ, Moore BB: Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol 2003; 29:537-44
41. McAnulty RJ, Hernandez-Rodriguez NA, Mutsaers SE, Coker RK, Laurent GJ: Indomethacin suppresses the antiproliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem J 1997; 321 (pt 3):639-43
42. Morsy MA, Isohama Y, Miyata T: Prostaglandin E(2) increases surfactant secretion via the EP(1) receptor in rat alveolar type II cells. Eur J Pharmacol 2001; 426:21-4
43. Church RJ, Jania LA, Koller BH: Prostaglandin E(2) produced by the lung augments the effector phase of allergic inflammation. J Immunol 2012; 188:4093-102
44. Sato T, Liu X, Nelson A, Nakanishi M, Kanaji N, Wang X, Kim M, Li Y, Sun J, Michalski J, Patil A, Basma H, Holz O, Magnussen H, Rennard SI: Reduced miR-146a increases prostaglandin E2in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med 2010; 182:1020-9
45. Sato T, Araki I, Kushikata T, Ohkawa H, Ishihara H, Matsuki A: Decreased hypothalamic prostaglandin D2 and prostaglandin E2 contents during isoflurane anaesthesia in rats. Can J Anaesth 1995; 42:1031-4
46. Molliex S, Crestani B, Dureuil B, Rolland C, Aubier M, Desmonts JM: Differential effects of isoflurane and i.v. anaesthetic agents on metabolism of alveolar type II cells. Br J Anaesth 1999; 82:767-9
47. Chen BC, Yu CC, Lei HC, Chang MS, Hsu MJ, Huang CL, Chen MC, Sheu JR, Chen TF, Chen TL, Inoue H, Lin CH: Bradykinin B2 receptor mediates NF-kappaB activation and cyclooxygenase-2 expression via the Ras/Raf-1/ERK pathway in human airway epithelial cells. J Immunol 2004; 173:5219-28
48. Hong SH, Choi HB, Kim SU, McLarnon JG: Mitochondrial ligand inhibits store-operated calcium influx and COX-2 production in human microglia. J Neurosci Res 2006; 83:1293-8
49. Mignen O, Thompson JL, Shuttleworth TJ: Orai1 subunit stoichiometry of the mammalian CRAC channel pore. J Physiol (Lond) 2008; 586:419-25
50. Bjurstöm H, Wang J, Wang J, Ericsson I, Bengtsson M, Liu Y, Kumar-Mendu S, Issazadeh-Navikas S, Birnir B: GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol 2008; 205:44-50
51. Gusarova GA, Trejo HE, Dada LA, Briva A, Welch LC, Hamanaka RB, Mutlu GM, Chandel NS, Prakriya M, Sznajder JI: Hypoxia leads to Na,K-ATPase downregulation via Ca(2+) release-activated Ca(2+) channels and AMPK activation. Mol Cell Biol 2011; 31:3546-56